These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9841617)
1. Gemfibrozil to prevent myocardial infarction. Rembold CM Ann Intern Med; 1998 Nov; 129(9):750. PubMed ID: 9841617 [No Abstract] [Full Text] [Related]
2. The cholesterol controversy. Rybinski EA BMJ; 1992 Mar; 304(6828):712. PubMed ID: 1571654 [No Abstract] [Full Text] [Related]
3. Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials. Doi T; Langsted A; Nordestgaard BG J Intern Med; 2024 May; 295(5):707-710. PubMed ID: 38343109 [No Abstract] [Full Text] [Related]
4. [Lipometabolic disorder--cholesterol and triglycerides]. Luley C Clin Res Cardiol; 2006; 95 Suppl 6():VI17-22. PubMed ID: 17013580 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results. Ros E; Zambón D; Bertomeu A; Cusó E; Sanllehy C; Casals E Arch Intern Med; 1991 Feb; 151(2):301-5. PubMed ID: 1992957 [TBL] [Abstract][Full Text] [Related]
6. Summaries for patients. Response to cholesterol-lowering drugs in patients with and without HIV infection. Ann Intern Med; 2009 Mar; 150(5):I38. PubMed ID: 19258553 [No Abstract] [Full Text] [Related]
7. Reduction in Q wave myocardial infarctions with gemfibrozil in the Helsinki Heart Study. Mänttäri M; Romo M; Manninen V; Koskinen P; Huttunen JK; Heinonen OP; Frick MH Am Heart J; 1990 May; 119(5):991-5. PubMed ID: 2330888 [TBL] [Abstract][Full Text] [Related]
8. Effects of bezafibrate and gemfibrozil on serum lipoproteins in primary hypercholesterolemia. Weisweiler P Arzneimittelforschung; 1988 Jul; 38(7):925-7. PubMed ID: 3207437 [TBL] [Abstract][Full Text] [Related]
9. [Gemfibrozil: new aspects in clinical use]. Tada N Nihon Rinsho; 2001 Mar; 59 Suppl 3():625-30. PubMed ID: 11347143 [No Abstract] [Full Text] [Related]
10. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention. Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831 [TBL] [Abstract][Full Text] [Related]
11. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels. McKenney JM; Barnett MD; Wright JT; Proctor JP Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045 [TBL] [Abstract][Full Text] [Related]
12. Treatment of type III hyperlipoproteinemia. Guyton JR Am Heart J; 1999 Jul; 138(1 Pt 1):17-8. PubMed ID: 10385757 [No Abstract] [Full Text] [Related]
14. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Bruckert E; De Gennes JL; Malbecq W; Baigts F Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530 [TBL] [Abstract][Full Text] [Related]
15. Comparison between duration dependent effects of Simvastatin and Gemfibrozil on dyslipidemia in patients with type 2 diabetes. Ashraf R; Amir K; Shaikh AR J Pak Med Assoc; 2005 Aug; 55(8):324-7. PubMed ID: 16164158 [TBL] [Abstract][Full Text] [Related]
16. Effects of lipid lowering on coronary plaques and coronary events. Roberts WC Am J Cardiol; 1997 Oct; 80(8B):8H-9H. PubMed ID: 9372992 [No Abstract] [Full Text] [Related]
17. [Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia]. Napoli C; Lepore S; Ambrosio G; Chiariello M Cardiologia; 1992 Nov; 37(11):761-8. PubMed ID: 1298545 [TBL] [Abstract][Full Text] [Related]